| Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer X Li, Z Sun, G Peng, Y Xiao, J Guo, B Wu, X Li, W Zhou, J Li, Z Li, C Bai, ... Theranostics 12 (2), 620, 2022 | 141 | 2022 |
| Immune checkpoint inhibitors in advanced or metastatic mucosal melanoma: a systematic review J Li, H Kan, L Zhao, Z Sun, C Bai Therapeutic Advances in Medical Oncology 12, 1758835920922028, 2020 | 44 | 2020 |
| Efficacy of immune checkpoint inhibitors in non-small-cell lung cancer patients with different metastatic sites: a systematic review and meta-analysis K Yang, J Li, C Bai, Z Sun, L Zhao Frontiers in oncology 10, 1098, 2020 | 40 | 2020 |
| Migraine and ischemic stroke: a Mendelian randomization study MJ Shu, JR Li, YC Zhu, H Shen Neurology and Therapy, 1-10, 2022 | 38 | 2022 |
| Participation of Black US residents in clinical trials of 24 cardiovascular drugs granted FDA approval, 2006-2020 S Chen, J Li JAMA Network Open 4 (3), e212640-e212640, 2021 | 26 | 2021 |
| Immune checkpoint markers in neuroendocrine carcinoma of the digestive system J Xing, H Ying, J Li, Y Gao, Z Sun, J Li, C Bai, Y Cheng, H Wu Frontiers in Oncology 10, 132, 2020 | 26 | 2020 |
| Retreatment with immune checkpoint inhibitors in solid tumors: a systematic review K Yang, J Li, Z Sun, L Zhao, C Bai Therapeutic Advances in Medical Oncology 12, 1758835920975353, 2020 | 24 | 2020 |
| CA19-9 elevation as an indication to start salvage treatment in surveillance after pancreatic cancer resection J Li, Z Li, H Kan, Z Sun, J Xing, Y Cheng, C Bai Pancreatology 19 (2), 302-306, 2019 | 22 | 2019 |
| Immune checkpoint inhibitors in advanced acral melanoma: a systematic review Q Zheng, J Li, H Zhang, Y Wang, S Zhang Frontiers in Oncology 10, 602705, 2020 | 20 | 2020 |
| Multi-modality treatment for patients with metastatic gastric cancer: a real-world study in China L Zhao, J Li, C Bai, Y Nie, G Lin Frontiers in Oncology 9, 1155, 2019 | 15 | 2019 |
| Artificial intelligence in melanoma: A systematic review S Zhang, Y Wang, Q Zheng, J Li, J Huang, X Long Journal of Cosmetic Dermatology 21 (11), 5993-6004, 2022 | 10 | 2022 |
| Impact of corticosteroids use on efficacy of immune checkpoint inhibitors in cancer patients: A meta-analysis. J Li, K Yang, L Zhao, C Bai, Z Sun Journal of Clinical Oncology 38 (15_suppl), e15234-e15234, 2020 | 9 | 2020 |
| Estimating the number of Chinese cancer patients eligible for and benefit from immune checkpoint inhibitors K Yang, J Li, L Zhao, Z Sun, C Bai Frontiers of Medicine 16 (5), 773-783, 2022 | 8 | 2022 |
| Health status of middle-aged and older cancer survivors: a nationwide cross-sectional study from the China Health and Retirement Longitudinal Study (CHARLS) J Li, H Pang, Z Sun, L Zhao, C Bai Annals of Translational Medicine 8 (5), 2020 | 8 | 2020 |
| Health digital technology in COVID-19 pandemic: experience from China M Shu, J Li BMJ Innovations, bmjinnov-2020-000477, 2020 | 6 | 2020 |
| Health-related quality of life in patients with advanced well-differentiated pancreatic and extrapancreatic neuroendocrine tumors treated with surufatinib versus placebo … J Li, Y Cheng, C Bai, J Xu, L Shen, J Li, Z Zhou, Z Li, Y Chi, X Yu, E Li, ... European Journal of Cancer 169, 1-9, 2022 | 4 | 2022 |
| Treatment-related adverse events as predictive biomarkers of efficacy in patients with advanced neuroendocrine tumors treated with surufatinib: results from two phase III studies J Li, Y Cheng, C Bai, J Xu, L Shen, Z Zhou, Z Li, Y Chi, X Yu, E Li, N Xu, ... ESMO open 7 (2), 100453, 2022 | 4 | 2022 |
| Genetically predicted telomere length and multiple sclerosis MJ Shu, J Li, YC Zhu Multiple Sclerosis and Related Disorders 60, 103731, 2022 | 4 | 2022 |
| Influenza in hospitalised patients with malignancy: a propensity score matching analysis J Li, D Zhang, Z Sun, C Bai, L Zhao ESMO open 5 (5), e000968, 2020 | 4 | 2020 |
| Use of participation to prevalence ratio for evaluating the representation status of women in oncology clinical trials S Chen, J Li, M Shu JAMA oncology 8 (3), 479-480, 2022 | 3 | 2022 |
